Efficacy and Safety of All-Oral Combination of Narlaprevir/Ritonavir and Daclatasvir in Treatment-Naїve Patients With Chronic Hepatitis C Genotype 1b

NCT03485846 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

105

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Hepatitis C Genotype 1b

Interventions

DRUG: Narlaprevir
DRUG: Ritonavir
DRUG: Daclatasvir

Sponsor

R-Pharm

Collaborators

[object Object]